Cited by 150Alzheimer's disease research and treatmentsNeurological Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.

Hypoxia‐inducible factors as neuroprotective agent in Alzheimer's disease

Ashok, Ben Sundra, Ajith, Thekkuttuparambil Ananthanarayanan, Sivanesan, Senthilkumar·2017·Clinical and Experimental Pharmacology and Physiology

DOI 10.1111/1440-1681.12717

Open this paper in CoChat — free account

Abstract

Summary: Beta amyloid (Aβ)‐42 peptide and phosphorylated tau protein have been demonstrated as the pathological hallmarks of Alzheimer's disease (AD). A gradual decline of oxygen and glucose supply to the brain during aging or hypoxia was manifested as a contributing factor to hypometabolism. The brain regions susceptible to hypometabolism are the hippocampus, entorhinal cortex and cognition‐associated neocortical regions like parietal, temporal and frontal cortex. In AD patients, the brain regions with hypometabolism can trigger overexpression of amyloid precursor protein and decrease the clearance of Aβ. Aβ and hypoxia can evoke inflammation, oxidative stress and finally neuronal cell death. Among the transcription factors involved in the compensatory mechanism, hypoxia‐inducible factor‐1 alpha (HIF‐1α) has a major role in the cellular adaptation by inducing the expression of several proteins, including vascular endothelial growth factor, erythropoietin and inducible nitric oxide synthase. Therefore, maintaining the HIF‐1α level by inhibiting the prolyl 4‐hydroxylase was effective to attenuate the nerve damage during hypoxia and postpone the incidence of AD. Agents such as iron chelators, and heavy metals like cobalt and nickel were demonstrated to be effective in maintaining the HIF‐1α level in the nerve. This review article discusses the possible role of HIF‐1α as a neuroprotector in AD and the future perspectives.

Integrity signals

Registry

Crossref · 10.1111/1440-1681.12717

Cites

101 of 101 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
Cellular and developmental control of O 2 homeostasis by hypoxia-inducible factor 1α
Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y., et al. (1998) · Genes & Development · doi:10.1101/gad.12.2.149 · Cited by 2,476
HIF-1α is essential for myeloid cell-mediated inflammation
Cramer, T., Yamanishi, Y., Clausen, B. E., Förster, I., Pawlinski, R., Mackman, N., Haase, V. H., Jaenisch, R., Corr, M., Nizet, V., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00154-5 · Cited by 2,046
Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1α during hypoxia
Chandel, N. S., McClintock, D. S., Feliciano, C. E., Wood, T. M., Melendez, J. A., Rodriguez, A. M., & Schumacker, P. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001914200 · Cited by 2,000
Regulation of Mammalian O 2 Homeostasis by Hypoxia-Inducible Factor 1
Semenza, G. L. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.551 · Cited by 1,914
HIF-1: mediator of physiological and pathophysiological responses to hypoxia
Semenza, G. L. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.88.4.1474 · Cited by 1,822
Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease – is this type 3 diabetes?
Steen, E., Terry, B. M., J. Rivera, E., Cannon, J. L., Neely, T. R., Tavares, R., Xu, X. J., Wands, J. R., & de la Monte, S. M. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2005-7107 · Cited by 1,703
VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia
Sun, Y., Jin, K., Xie, L., Childs, J., Mao, X. O., Logvinova, A. V., & Greenberg, D. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17977 · Cited by 1,201
VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia
Sun, Y., Jin, K., Xie, L., Childs, J., Mao, X. O., Logvinova, A., & Greenberg, D. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317977 · Cited by 1,189
Metal-Protein Attenuation With Iodochlorhydroxyquin (Clioquinol) Targeting Aβ Amyloid Deposition and Toxicity in Alzheimer Disease: A Pilot Phase 2 Clinical Trial
Ritchie, C. W., Bush, A. I., Mackinnon, A., Macfarlane, S., Mastwyk, M., MacGregor, L., Kiers, L., Cherny, R., Li, Q.-X., Tammer, A., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.12.1685 · Cited by 988
Mitochondria and neuronal activity
Kann, O., & Kovács, R. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00222.2006 · Cited by 871
Signal transduction to hypoxia-inducible factor 1
Semenza, G. L. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01168-1 · Cited by 860
Normal and Abnormal Biology of the Beta-Amyloid Precursor Protein
Selkoe, D. J. (1994) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.17.030194.002421 · Cited by 834
Brain insulin and insulin receptors in aging and sporadic Alzheimer’s disease
Frölich, L., Blum-Degen, D., Bernstein, H.-G., Engelsberger, S., Humrich, J., Laufer, S., Muschner, D., Thalheimer, A., Türk, A., Hoyer, S., et al. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050068 · Cited by 748
Regulation and Destabilization of HIF-1α by ARD1-Mediated Acetylation
Jeong, J.-W., Bae, M.-K., Ahn, M.-Y., Kim, S.-H., Sohn, T.-K., Bae, M.-H., Yoo, M.-A., Song, E. J., Lee, K.-J., & Kim, K.-W. (2002) · Cell · doi:10.1016/s0092-8674(02)01085-1 · Cited by 716
Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis
Karhausen, J., Furuta, G. T., Tomaszewski, J. E., Johnson, R. S., Colgan, S. P., & Haase, V. H. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421086 · Cited by 655
Brain fuel metabolism, aging, and Alzheimer’s disease
Cunnane, S. C., Nugent, S., Roy, M., Courchesne‐Loyer, A., Croteau, É., Tremblay, S., Castellano, A., Pifferi, F., Bocti, C., Paquet, N., et al. (2010) · Nutrition · doi:10.1016/j.nut.2010.07.021 · Cited by 633
Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression
Sun, X., He, G., Qing, H., Zhou, W., Dobie, F., Cai, F., Staufenbiel, M., Huang, L. E., & Song, W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606298103 · Cited by 605
Hypoxia causes the activation of nuclear factor kappa B through the phosphorylation of I kappa B alpha on tyrosine residues.
Koong, A. C., Chen, E. Y., & Giaccia, A. J. (1994) · PubMed · Cited by 445
Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease
Liu, F., Shi, J., Tanimukai, H., Gu, J., Gu, J., Grundke-Iqbal, I., Iqbal, K., & Gong, C.-X. (2009) · Brain · doi:10.1093/brain/awp099 · Cited by 439
Hypoxia-inducible Factor 1α (HIF-1α)-mediated Hypoxia Increases BACE1 Expression and β-Amyloid Generation
Zhang, X., Zhou, K., Wang, R., Cui, J., Lipton, S. A., Liao, F.-F., Xu, H., & Zhang, Y.-W. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608856200 · Cited by 436
Hypoxia-inducible factor–dependent induction of netrin-1 dampens inflammation caused by hypoxia
Rosenberger, P., Schwab, J. M., Mirakaj, V., Masekowsky, E., Mager, A., Morote–Garcia, J. C., Unertl, K. E., & Eltzschig, H. K. (2009) · Nature Immunology · doi:10.1038/ni.1683 · Cited by 406
Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease
Liu, Y. M., Liu, F., Iqbal, K., Grundke, I., & Gong, C. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.12.035 · Cited by 396
Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative
Gabuzda, D., Busciglio, J., Chen, L. B., Matsudaira, P., & Yankner, B. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36875-8 · Cited by 373
Interdependent roles for hypoxia inducible factor and nuclear factor‐κB in hypoxic inflammation
Taylor, C. T. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2008.157669 · Cited by 354
Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly
Convit, A., Wolf, O. T., Tarshish, C., & de Leon, M. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0336073100 · Cited by 347
Cellular and Molecular Mechanisms Underlying Perturbed Energy Metabolism and Neuronal Degeneration in Alzheimer's and Parkinson's Diseases
Mattson, M. P., Pedersen, W. A., Duan, W., Culmsee, C., & Camandola, S. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07824.x · Cited by 343
Reduced hippocampal metabolism in MCI and AD
Mosconi, L., Tsui, W. H., Santi, S. D., Li, J., Rusinek, H., Convit, A. J., Li, Y., Boppana, M., & de Leon, M. J. (2005) · Neurology · doi:10.1212/01.wnl.0000163856.13524.08 · Cited by 335
Insulin resistance in the nervous system
Kim, B., & Feldman, E. L. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2011.12.004 · Cited by 321
Protection from Oxidative Stress–Induced Apoptosis in Cortical Neuronal Cultures by Iron Chelators Is Associated with Enhanced DNA Binding of Hypoxia-Inducible Factor-1 and ATF-1/CREB and Increased Expression of Glycolytic Enzymes, p21waf1/cip1, and Erythropoietin
Zaman, K., Ryu, H., Hall, D. H., O’Donovan, K., Lin, K., Miller, M. P., Marquis, J. C., Baraban, J. M., Semenza, G. L., & Ratan, R. R. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-22-09821.1999 · Cited by 319
Differential Gene Up-Regulation by Hypoxia-Inducible Factor-1α and Hypoxia-Inducible Factor-2α in HEK293T Cells
Wang, V., Davis, D. A., Haque, M., Huang, E. L., & Yarchoan, R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4130 · Cited by 317
Multiple Splice Variants of the Human HIF-3α Locus Are Targets of the von Hippel-Lindau E3 Ubiquitin Ligase Complex
Maynard, M. A., Qi, H., Chung, J., Lee, E. H. L., Kondo, Y., Hara, S., Conaway, R. C., Conaway, J. W., & Ohh, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208681200 · Cited by 283
Hypoxia-inducible Factor Prolyl 4-Hydroxylase Inhibition
Siddiq, A., Ayoub, I. A., Chavez, J. C., Aminova, L. R., Shah, S., LaManna, J. C., Patton, S. M., Connor, J. R., Cherny, R. A., Volitakis, I., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504963200 · Cited by 280
Paracrine and Autocrine Functions of Neuronal Vascular Endothelial Growth Factor (VEGF) in the Central Nervous System
Ogunshola, O. O., Antic, A., Donoghue, M. J., Fan, S.-Y., Kim, H., Stewart, W. B., Jr., Madri, J. A., & Ment, L. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111085200 · Cited by 268
Hypoxic but not anoxic stabilization of HIF-1α requires mitochondrial reactive oxygen species
Schroedl, C., McClintock, D. S., Budinger, G. R. S., & Chandel, N. S. (2002) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00014.2002 · Cited by 266
The up‐regulation of BACE1 mediated by hypoxia and ischemic injury: role of oxidative stress and HIF1α
Guglielmotto, M., Aragno, M., Autelli, R., Giliberto, L., Novo, E., Colombatto, S., Danni, O., Parola, M., Smith, M. A., Perry, G. L., et al. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05858.x · Cited by 245
Dysregulation of Insulin Signaling, Glucose Transporters, O-GlcNAcylation, and Phosphorylation of Tau and Neurofilaments in the Brain
Deng, Y., Li, B., Liu, Y. M., Iqbal, K., Grundke, I., & Gong, C. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.090157 · Cited by 233
Involvement of Hypoxia-Inducible Factor 1 in Human Cancer.
Semenza, G. L. (2002) · Internal Medicine · doi:10.2169/internalmedicine.41.79 · Cited by 211
Post-mortem assessment of hypoperfusion of cerebral cortex in Alzheimer’s disease and vascular dementia
Thomas, T. L., Miners, J. S., & Love, S. (2015) · Brain · doi:10.1093/brain/awv025 · Cited by 194
Brain glucose transporters, O‐GlcNAcylation and phosphorylation of tau in diabetes and Alzheimer’s disease
Liu, Y. M., Liu, F., Grundke, I., Iqbal, K., & Gong, C. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06320.x · Cited by 193
Multiple Defects in Energy Metabolism in Alzheimers Disease
Ferreira, I. L., Resende, R., Ferreiro, E. B., Rego, A. C., & Pereira, C. (2010) · Current Drug Targets · doi:10.2174/1389450111007011193 · Cited by 185
Topography of Cross-sectional and Longitudinal Glucose Metabolic Deficits in Alzheimer's Disease: Pathophysiologic Implications
Smith, G. S. (1992) · Archives of Neurology · doi:10.1001/archneur.1992.00530350056020 · Cited by 178
Causes and Consequences of Disturbances of Cerebral Glucose Metabolism in Sporadic Alzheimer Disease: Therapeutic Implications
Hoyer, S. (2004) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-8969-7_8 · Cited by 173
Vascular Endothelial Growth Factor Overexpression Delays Neurodegeneration and Prolongs Survival in Amyotrophic Lateral Sclerosis Mice
Wang, Y., Mao, X. O., Xie, L., Banwait, S., Marti, H. H., Greenberg, D. A., & Jin, K. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4433-06.2007 · Cited by 168
Erythropoietin protects primary hippocampal neurons increasing the expression of brain‐derived neurotrophic factor
Viviani, B., Bartesaghi, S., Corsini, E., Villa, P., Ghezzi, P., Garau, A., Galli, C. L., & Marinovich, M. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03033.x · Cited by 165
Interactions between nitric oxide and hypoxia-inducible factor signaling pathways in inflammatory disease
Olson, N. C., & van der Vliet, A. (2011) · Nitric Oxide · doi:10.1016/j.niox.2010.12.010 · Cited by 161
Synaptotoxic Amyloid-β Oligomers: A Molecular Basis for the Cause, Diagnosis, and Treatment of Alzheimer's Disease?
Klein, W. L. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-129039 · Cited by 145
A targeted antioxidant reveals the importance of mitochondrial reactive oxygen species in the hypoxic signaling of HIF‐1α
Sanjuán-Pla, A., Cervera, A. M., Apostolova, N., Garcia-Bou, R., Víctor, V. M., Murphy, M. P., & McCreath, K. J. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.03.088 · Cited by 134
Pharmacological Treatment of Alzheimer Disease
Massoud, F., & Léger, G. C. (2011) · The Canadian Journal of Psychiatry · doi:10.1177/070674371105601003 · Cited by 130
Inhibition of prolyl hydroxylases by dimethyloxaloylglycine after stroke reduces ischemic brain injury and requires hypoxia inducible factor-1α
Ogle, M. E., Gu, X., Espinera, A. R., & Wei, L. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.10.020 · Cited by 129
Gene expression profiling reveals the profound upregulation of hypoxia-responsive genes in primary human astrocytes
Mense, S. M., Sengupta, A., Zhou, M., Lan, C., Bentsman, G., Volsky, D. J., & Li, Z. (2006) · Physiological Genomics · doi:10.1152/physiolgenomics.00315.2005 · Cited by 124
Neuroprotection of deferoxamine on rotenone-induced injury via accumulation of HIF-1α and induction of autophagy in SH-SY5Y cells
Wu, Y., Li, X., Xie, W., Jankovic, J. J., Le, W., & Pan, T. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.05.008 · Cited by 115
Hypoxia in cancer cell metabolism and pH regulation
Brahimi-Horn, M. C., & Pouysségur, J. (2007) · Essays in Biochemistry · doi:10.1042/bse0430165 · Cited by 113
Healthy Brain Aging: Role of Exercise and Physical Activity
Rolland, Y., Abellan van Kan, G., & Vellas, B. (2010) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2009.11.002 · Cited by 103
Neuroprotection by Dimethyloxalylglycine following Permanent and Transient Focal Cerebral Ischemia in Rats
Nagel, S., Papadakis, M., Chen, R., Hoyte, L. C., Brooks, K. J., Gallichan, D., Sibson, N. R., Pugh, C. W., & Buchan, A. M. (2010) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.60 · Cited by 100
The Treatment of Alzheimer Disease
Winslow, B. T., Onysko, M. K., Stob, C. M., & Hazlewood, K. A. (2008) · Springer eBooks · doi:10.1007/978-3-540-87523-9_6 · Cited by 100
Prolyl Hydroxylase Domain Inhibitors: A Route to HIF Activation and Neuroprotection
Harten, S. K., Ashcroft, M. A., & Maxwell, P. H. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2870 · Cited by 99
Oxidative phosphorylation defects and Alzheimer's disease
Shoffner, J. M. (1997) · Neurogenetics · doi:10.1007/s100480050002 · Cited by 98
Inhibition of Prolyl Hydroxylase Protects against 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Neurotoxicity
Lee, D. W., Rajagopalan, S., Siddiq, A., Gwiazda, R. H., Yang, L., Beal, M. F., Ratan, R. R., & Andersen, J. K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.000638 · Cited by 97
Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibition: Robust New Target or Another Big Bust for Stroke Therapeutics?
Karuppagounder, S. S., & Ratan, R. R. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.28 · Cited by 97
Changes in Brain Glucose Metabolism as a Key to the Pathogenesis of Alzheimer’s Disease
Meier‐Ruge, W., Bertoni–Freddari, C., & Iwangoff, P. (2009) · Gerontology · doi:10.1159/000213592 · Cited by 94
Developmental factors regulating susceptibility to perinatal brain injury and seizures
Jensen, F. E. (2006) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e328010c536 · Cited by 93
Abnormalities of Energy Metabolism in Alzheimer's Disease Studied with PETa
Heiss, W., Szelies, B., KESSLER, J., & Herholz, K. (1991) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1991.tb00192.x · Cited by 93
The induction of HIF‐1 reduces astrocyte activation by amyloid beta peptide
Schubert, D. A., Soucek, T., & Blouw, B. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06712.x · Cited by 90
Hypoxia Signaling to Genes: Significance in Alzheimer's Disease
Bazan, N. G., Peláez, R. P., & Lukiw, W. J. (2002) · Molecular Neurobiology · doi:10.1385/mn:26:2-3:283 · Cited by 88
Age-dependent metabolic dysregulation in cancer and Alzheimer’s disease
Harris, R. A., Tindale, L. C., & Cumming, R. C. (2014) · Biogerontology · doi:10.1007/s10522-014-9534-z · Cited by 85
Pathogenesis of Abeta Oligomers in Synaptic Failure
Sivanesan, S., Tan, A., & Rajadas, J. (2013) · Current Alzheimer Research · doi:10.2174/1567205011310030011 · Cited by 85
Self-citation
Hypoxia-Inducible Factor-2α Is an Essential Catabolic Regulator of Inflammatory Rheumatoid Arthritis
Ryu, J., Chae, C.-S., Kwak, J.-S., Oh, H., Shin, Y., Huh, Y. H., Lee, C., Park, Y.-W., Chun, C. H., Kim, Y., et al. (2014) · PLoS Biology · doi:10.1371/journal.pbio.1001881 · Cited by 84
The role of hypoxia-inducible transcription factors in the hypoxic neonatal brain
Trollmann, R., & Gassmann, M. (2009) · Brain and Development · doi:10.1016/j.braindev.2009.03.007 · Cited by 75
Utilization of an In Vivo Reporter for High Throughput Identification of Branched Small Molecule Regulators of Hypoxic Adaptation
Smirnova, N. A., Rakhman, I., Moroz, N., Basso, M., Payappilly, J. B., Kazakov, S. V., Hernandez-Guzman, F. G., Gaisina, I. N., Kozikowski, A. P., Ratan, R. R., et al. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.03.008 · Cited by 75
Vascular endothelial growth factor prevents G93A‐SOD1‐induced motor neuron degeneration
Lunn, J. S., Sakowski, S. A., Kim, B., Rosenberg, A. A., & Feldman, E. L. (2009) · Developmental Neurobiology · doi:10.1002/dneu.20747 · Cited by 74
Proper Names in Patients With Early Alzheimer’s Disease
Semenza, C., Mondini, S., Borgo, F., Pasini, M., & Sgaramella, M. T. (2003) · Neurocase · doi:10.1076/neur.9.1.63.14370 · Cited by 70
Hypoxia-inducible factor 1 in autoimmune diseases
Deng, W., Feng, X., Li, X., Wang, D., & Sun, L. (2016) · Cellular Immunology · doi:10.1016/j.cellimm.2016.04.001 · Cited by 70
Up-Regulation of Hypoxia-Inducible Factor (HIF)-1α and HIF-Target Genes in Cortical Neurons by the Novel Multifunctional Iron Chelator Anti-Alzheimer Drug, M30
Avramovich‐Tirosh, Y., Bar‐Am, O., Amit, T., Youdim, M. B. H., & Weinreb, O. (2010) · Current Alzheimer Research · doi:10.2174/156720510791162403 · Cited by 70
Respiratory impairment in a mouse model of amyotrophic lateral sclerosis
Tankersley, C. G., Haenggeli, C., & Rothstein, J. D. (2006) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00193.2006 · Cited by 66
HIF Prolyl Hydroxylase Inhibitors Prevent Neuronal Death Induced by Mitochondrial Toxins: Therapeutic Implications for Huntington's Disease and Alzheimer's Disease
Niatsetskaya, Z. V., Basso, M., Speer, R. E., McConoughey, S. J., Coppola, G., Ma, T. C., & Ratan, R. R. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2800 · Cited by 64
The effects of perturbed energy metabolism on the processing of amyloid precursor protein in PC12 cells
Webster, M.-T., Pearce, B. R., Bowen, D. M., & Francis, P. T. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050098 · Cited by 62
Induction of hypoxia inducible factor‐1 attenuates metabolic insults induced by 3‐nitropropionic acid in rat C6 glioma cells
Yang, Y., Ju, T., & Yang, D. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03032.x · Cited by 56
Effect of Ganoderma lucidum on the activities of mitochondrial dehydrogenases and complex I and II of electron transport chain in the brain of aged rats
Ajith, T. A., Sudheesh, N. P., Roshny, D., Abishek, G., & Janardhanan, K. K. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.11.002 · Cited by 55
Self-citation
Therapeutic potential of Ganoderma lucidum (Fr.) P. Karst. against the declined antioxidant status in the mitochondria of post-mitotic tissues of aged mice
Sudheesh, N. P., Ajith, T. A., Ramnath, V., & Janardhanan, K. K. (2009) · Clinical Nutrition · doi:10.1016/j.clnu.2009.12.003 · Cited by 54
Self-citation
Inhibition of HIF-prolyl-4-hydroxylases prevents mitochondrial impairment and cell death in a model of neuronal oxytosis
Neitemeier, S., Dolga, A. M., Honrath, B., Karuppagounder, S. S., Alim, I., Ratan, R. R., & Culmsee, C. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.107 · Cited by 48
Recombinant human erythropoietin suppresses symptom onset and progression of G93A‐SOD1 mouse model of ALS by preventing motor neuron death and inflammation
Koh, S., Kim, Y., Kim, H. Y., Cho, G. W., Kim, K. S., & Kim, S. H. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05471.x · Cited by 47
Vascular endothelial growth factor in amyotrophic lateral sclerosis and other neurodegenerative diseases
Bogaert, E., Damme, P. V., Bosch, L. V. D., & Robberecht, W. (2006) · Muscle & Nerve · doi:10.1002/mus.20609 · Cited by 45
Deregulation of HIF1-alpha and hypoxia-regulated pathways in hepatocellular carcinoma and corresponding non-malignant liver tissue—influence of a modulated host stroma on the prognosis of HCC
Simon, F., Bockhorn, M., Praha, C., Baba, H. A., Broelsch, C. E., Frilling, A., & Weber, F. (2010) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-009-0590-9 · Cited by 41
Multi-target, Neuroprotective and Neurorestorative M30 Improves Cognitive Impairment and Reduces Alzheimer's-Like Neuropathology and Age-Related Alterations in Mice
Kupershmidt, L., Amit, T., Bar‐Am, O., Weinreb, O., & Youdim, M. B. H. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8304-7 · Cited by 41
The Novel Multi-Target Iron Chelator, M30 Modulates HIF-1α-Related Glycolytic Genes and Insulin Signaling Pathway in the Frontal Cortex of APP/PS1 Alzheimer’s Disease Mice
Mechlovich, D., Amit, T., Bar‐Am, O., Mandel, S. A., Youdim, M. B. H., & Weinreb, O. (2014) · Current Alzheimer Research · doi:10.2174/1567205010666131212112529 · Cited by 40
Primary breast cancer induces pulmonary vascular hyperpermeability and promotes metastasis via the VEGF–PKC pathway
Jiang, M., Qin, C., & Han, M. (2015) · Molecular Carcinogenesis · doi:10.1002/mc.22352 · Cited by 37
A viral vector expressing hypoxia-inducible factor 1 alpha inhibits hippocampal neuronal apoptosis
Sun, Y., Chai, X.-Q., Kong, W., Liu, L., Yu, W., & Zhang, Z. (2014) · Neural Regeneration Research · doi:10.4103/1673-5374.135317 · Cited by 36
Berberine Preconditioning Protects Neurons Against Ischemia via Sphingosine-1-Phosphate and Hypoxia-Inducible Factor-1α
Zhang, Q., Bian, H., Guo, L., & Zhu, H. (2016) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x16500518 · Cited by 27
Expression of hypoxia-inducible factor-1α affects tumor proliferation and antiapoptosis in surgically resected lung cancer
Takasaki, C., Kobayashi, M., Ishibashi, H., Akashi, T., & Okubo, K. (2016) · Molecular and Clinical Oncology · doi:10.3892/mco.2016.937 · Cited by 27
Differential Hypometabolism Patterns according to Mild Cognitive Impairment Subtypes
Jauhiainen, A. M., Kangasmaa, T. S., Rusanen, M., Niskanen, E. I., Tervo, S., Kivipelto, M., Vanninen, R. L., Kuikka, J. T., & Soininen, H. S. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000167880 · Cited by 22
Treatment of Alzheimer Disease
Hachinski, V. (1999) · Archives of Neurology · doi:10.1001/archneur.56.6.735 · Cited by 20
Mitochondrial Pharmaceutics: A New Therapeutic Strategy to Ameliorate Oxidative Stress in Alzheimer’s Disease
Ajith, T. A., & Padmajanair, G. (2015) · Current Aging Science · doi:10.2174/187460980803151027115147 · Cited by 19
Self-citation
A Possible Novel Anti-Inflammatory Mechanism for the Pharmacological Prolyl Hydroxylase Inhibitor 3,4-Dihydroxybenzoate: Implications for Use as a Therapeutic for Parkinson’s Disease
Chinta, S. J., Rajagopalan, S., Ganesan, A., & Andersen, J. K. (2012) · Parkinson s Disease · doi:10.1155/2012/364684 · Cited by 17
HIF-1α-induced β-catenin activation prevents prion-mediated neurotoxicity
Jeong, J., & Park, S. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1457 · Cited by 13
[Outline of glucose metabolism and its regulations].
Kuzuya, T. (1990) · PubMed · Cited by 8
[Effect of intracerebroventricular injection of rAAV-HIF-1α on hippocampal neuronal apoptosis in a rat model of Alzheimer disease].
Sun, Y., Hao, H.-Q., Kong, W.-N., Liu, L., & Xi-qing, C. (2010) · PubMed · Cited by 5
[Phosphoinositide 3-kinase/Akt pathway involved in regulation of hypoxia inducible factor 1alpha in hypoxia ischemia brain damage of neonatal rats].
Li, L., Qu, Y., Mao, M., & Mu, D. (2008) · PubMed · Cited by 5
Effect of palladium α-lipoic acid complex on energy in the brain mitochondria of aged rats.
Ajith, T. A., Nima, N., Veena, R. K., Janardhanan, K. K., & Antonawich, F. J. (2014) · PubMed · Cited by 5
Self-citation
[Relationship between hypoxia-inducible factor-1alpha expression and extracellular signal-regulated kinase in hypoxic-ischemic cortical neurons].
Zhang, L., Qu, Y., Zhang, X., Yang, C., Mao, M., & Mu, D. (2009) · PubMed · Cited by 2

Sorted by citations

Microglia in Alzheimer's disease at single-cell level. Are there common patterns in humans and mice?
Chen, Y., & Colonna, M. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20202717 · Cited by 339
Hypoxia and brain aging: Neurodegeneration or neuroprotection?
Burtscher, J., Mallet, R. T., Burtscher, M., & Millet, G. P. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101343 · Cited by 359
Ferritinophagy/ferroptosis: Iron‐related newcomers in human diseases
Tang, M., Chen, Z., Wu, D., & Chen, L. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26954 · Cited by 292
Ferroptosis and Its Potential Role in Human Diseases
Han, C., Liu, Y., Dai, R., Ismail, N., Su, W., & Li, B. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00239 · Cited by 283
HIF-1α promotes SARS-CoV-2 infection and aggravates inflammatory responses to COVID-19
Tian, M., Liu, W., Li, X., Zhao, P., Shereen, M. A., Zhu, C., Huang, S., Liu, S., Yu, X., Yue, M., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00726-w · Cited by 249

See all 150

Authors: Ashok, B. S., Ajith, T. A., & Sivanesan, S.
Affiliations: Sri Ramachandra Institute of Higher Education and Research (IN)
Amala Institute of Medical Sciences (IN)
Saveetha University (IN)
Corresponding author: Ajith, Thekkuttuparambil Ananthanarayanan
Sivanesan, Senthilkumar
ORCID: Ajith, Thekkuttuparambil Ananthanarayanan
Sivanesan, Senthilkumar
Venue: Clinical and Experimental Pharmacology and Physiology
Publisher: Wiley
Published: 2017-02-14
Volume: 44
Issue: 3
Pages: 327-334
ISSN: 0305-1870 (ISSN-L)
1440-1681
DOI: 10.1111/1440-1681.12717
OpenAlex: W2564524475
Cited by: 150
References: 100
Citations by year: 2026: 6 · 2025: 10 · 2024: 31 · 2023: 11 · 2022: 15 · 2021: 35 · 2020: 13 · 2019: 14 · 2018: 9 · 2017: 6
FWCI: 1.13
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Clinical and Experimental Pharmacology and Physiology (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: hypoxia-inducible factor-1α, Alzheimer's disease, neuroprotection, amyloid-beta, tau phosphorylation, brain hypometabolism, oxidative stress, neuroinflammation, iron chelators, cobalt, nickel, vascular endothelial growth factor, erythropoietin, inducible nitric oxide synthase
MeSH terms: Alzheimer Disease, Animals, Humans, Peptide Fragments, Amyloid beta-Peptides, Neuroprotective Agents, Hypoxia-Inducible Factor 1, alpha Subunit, Drug Discovery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Hypoxia‐inducible factors as neuroprotective agent in Alzheimer's disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks